Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Research and development spending
3Y CAGR
+118.3%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
10.4x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $94.79M | +55.6% |
| 2024 | $60.94M | +117.6% |
| 2023 | $28.00M | +207.2% |
| 2022 | $9.12M | - |